A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD).

27 August 2017 (14:00 - 18:00)
Organised by:
Add to my library
Congress Presentation Part of: Poster session 3 - Acute Heart Failure (AHF) Heart failure, other ESC Premium Access ESC Congress 2017

About the speaker

Photo

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)

16 More presentations in this session

Presentation thumbnail
Associate Professor P. Badertscher (Basel, CH)
Presentation thumbnail
Assistant Professor W. Huang (Taipei, TW)
Presentation thumbnail
Doctor T. Sakaguchi (Osaka, JP)
Presentation thumbnail
Doctor A. shoaib (Stoke-on-Trent, GB)
Presentation thumbnail
Assistant Professor F. Diaz (Santiago, CL)

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET